Stargardt Disease Treatment in North Andover, MA

If you or a loved one has been diagnosed with Stargardt disease, finding specialized eye care close to home matters. Patients throughout North Andover, MA, and the surrounding communities of Andover, Lawrence, Haverhill, Methuen, and Dracut trust Boston Vision for compassionate, research-driven care for complex retinal diseases and genetic disorders affecting vision. Our physicians combine deep clinical expertise with a genuine commitment to patient education, helping you understand your diagnosis, your options, and what to expect at every step. To speak with a member of our team, call us today at (617) 566-0062.

Understanding Stargardt Disease and How It Affects Vision

Stargardt disease is a rare inherited retinal disorder that primarily affects the retinal pigment epithelium and the macula, the small central area of the retina responsible for sharp, detailed vision. It is among the most common forms of inherited macular degeneration, and it can affect both children and adults. The condition leads to progressive central vision loss over time, though the rate and severity vary significantly from person to person.

Stargardt disease is caused by mutations in the ABCA4 gene, which disrupts how the retinal pigment epithelium processes vitamin A byproducts. Over time, this leads to the buildup of toxic deposits that damage photoreceptor cells. Patients often first notice difficulty reading, blurred or distorted central vision, or sensitivity to light. Peripheral vision is typically preserved, which distinguishes Stargardt from other ophthalmic diseases such as retinitis pigmentosa or usher syndrome.

Because symptoms can overlap with age-related macular degeneration and other retinal conditions, an accurate diagnosis is essential before any course of care is considered.

Pursuing an Accurate Diagnosis at Boston Vision

Our ophthalmologists use a comprehensive diagnostic approach to evaluate patients with suspected Stargardt disease or other inherited retinal disorders. This includes a thorough review of medical history, assessment of visual acuity, and advanced imaging such as optical coherence tomography to evaluate the health of the retina and optic nerve in detail.

Genetic testing is an important part of the diagnostic process. Confirming specific genetic mutations not only establishes an accurate diagnosis but may also determine eligibility for clinical trials and emerging gene therapy programs. Our physicians work closely with patients to interpret findings in plain language and discuss what each result means for long-term vision care.

Dr. Samir Melki, MD, PhD, Founder of Boston Vision, completed a fellowship in Cornea and Refractive Surgery at the Massachusetts Eye and Ear Infirmary at Harvard Medical School and has served as an Associate Professor of Ophthalmology at Harvard Medical School since 2015. Dr. Jason Brenner, MD, is a board-certified ophthalmologist and staff surgeon at Beth Israel Deaconess Medical Center, also holding a lecturer appointment at Harvard Medical School. Together, they lead a team deeply embedded in ophthalmic research and academic medicine.

Current Treatment Options and Comprehensive Care

There is currently no FDA-approved medical cure for Stargardt disease, but medical and surgical treatment strategies exist to help manage symptoms, preserve remaining vision, and support quality of life. Our team works with each patient to develop a personalized care plan tailored to their stage of disease, genetic profile, and visual needs.

Current approaches to comprehensive care may include:

  • Low vision rehabilitation and guidance on corrective lenses and contact lenses designed to support functional vision
  • Monitoring and management of associated conditions, such as dry AMD, which shares overlapping features with Stargardt disease
  • Referral to clinical trials evaluating gene therapy and other emerging treatments for inherited retinal disorders
  • Genetic counseling coordination for patients and families affected by hereditary retinal diseases
  • Coordination with optometrists and other specialists to support ongoing eye care needs

Clinical trials are an active and important area for patients with Stargardt disease. Gene therapy approaches targeting the ABCA4 mutation are currently being studied, and early research suggests that some patients may benefit as these therapies move through development. Our physicians stay current with ophthalmic research and can help you understand whether participation in clinical trials may be appropriate for your situation.

Ready to speak with a specialist? Call Boston Vision at (617) 566-0062 or request an appointment online.

What to Expect During Your Visit

Your first appointment at our Andover office focuses on understanding your complete eye health history and establishing a clear picture of your current vision and retinal health. Patients referred by their primary care physician or a general ophthalmologist are welcome, though a referral is not required.

During your consultation, you will meet directly with your treating physician. Boston Vision is built on a one-on-one model, meaning you speak with the doctor who will oversee your care, not a technician or assistant. Your surgeon’s direct contact information is made available to you, providing ongoing access throughout your care.

Diagnostic imaging, including optical coherence tomography and other specialized testing, may be performed during your first visit or scheduled as part of a follow-up evaluation. Depending on your findings, additional training resources, low vision specialists, or genetic counseling services may be coordinated as part of your plan.

Why Patients in North Andover, MA Choose Boston Vision

Boston Vision operates as a private academic medicine practice. Our physicians hold active affiliations with Harvard Medical School, Beth Israel Deaconess Medical Center, and Mass Eye and Ear, and publish original research in peer-reviewed journals and medical textbooks. This academic focus means our patients benefit from evidence-based, up-to-date approaches to complex diseases of the eye.

Patients from North Andover, Andover, Lawrence, Haverhill, and Methuen choose our practice because they receive access to subspecialty-level ophthalmology care without traveling to Boston. Our Andover location at 323 Lowell Street, Suite 102, is easily accessible from Route 495 and serves the greater Merrimack Valley region. With seven locations across Greater Boston, additional appointments or surgical procedures can be scheduled at a location most convenient for you.

Our physicians also bring international expertise to their local practice, with experience in surgical procedures performed in the United Kingdom and complex corneal surgeries in the Middle East. That depth of experience informs how we approach every patient, whether they are dealing with early-stage inherited retinal disease or more advanced central vision loss.

Frequently Asked Questions About Stargardt Disease Treatment in North Andover, MA

Have more questions? Call us at (617) 566-0062 or contact our team online to schedule a consultation with one of our physicians.

What is Stargardt disease, and how is it different from age-related macular degeneration?

Stargardt disease is a genetic retinal disorder caused by mutations in the ABCA4 gene, while age-related macular degeneration develops from a combination of aging, environmental, and genetic factors. Both affect the macula and cause central vision loss, but Stargardt disease is more commonly diagnosed in children and young adults. An accurate diagnosis from a qualified ophthalmologist is essential to distinguish between the two conditions.

Is there a treatment for Stargardt disease?

Currently, there is no FDA-approved medical or surgical treatment that halts or reverses Stargardt disease. However, supportive care, low vision rehabilitation, and participation in clinical trials focused on gene therapy may help patients manage their condition and potentially slow progression. Your physician at Boston Vision can review current clinical trials that may be relevant to your case.

How is Stargardt disease diagnosed?

Diagnosis typically involves a comprehensive eye exam, visual acuity testing, optical coherence tomography, and genetic testing to confirm ABCA4 mutations. At Boston Vision, our physicians conduct thorough evaluations to reach an accurate diagnosis and develop an appropriate care plan. Early diagnosis helps identify clinical trial eligibility and guides long-term monitoring.

Can children be diagnosed with Stargardt disease?

Yes. Stargardt disease frequently presents in childhood or adolescence, though it can also affect adults. Children who show signs of unexplained central vision loss should be evaluated by an ophthalmologist experienced with inherited retinal disorders. Our team is experienced in working with patients of all ages dealing with genetic eye diseases.

What role does gene therapy play in treating Stargardt disease?

Gene therapy is one of the most actively researched treatment areas for inherited retinal diseases, including Stargardt disease. Clinical trials are evaluating therapies designed to address the underlying ABCA4 genetic mutation. Our physicians follow ongoing ophthalmic research closely and can discuss whether current clinical trials may be appropriate for you.

Do I need a referral to see a specialist at Boston Vision?

A referral from your primary care physician or optometrist is not required to schedule an appointment at Boston Vision. However, bringing any prior diagnostic records, imaging, or genetic testing results from previous providers can help our team conduct a more complete evaluation during your first visit.

How does dry AMD relate to Stargardt disease?

Dry AMD and Stargardt disease share overlapping features, including damage to the retinal pigment epithelium and progressive central vision loss. Accurate diagnosis is important because the underlying causes differ, and the approach to medical and surgical treatment may vary. Our physicians evaluate patients carefully to distinguish between these conditions and related retinal diseases.

What should I expect at my first appointment?

Your first visit will include a detailed review of your symptoms, medical history, and any prior diagnoses. Imaging, such as optical coherence tomography, may be performed, and your physician will discuss findings with you directly. You will leave with a clear understanding of your diagnosis and a personalized plan for ongoing eye care.

Can contact lenses or corrective lenses help with Stargardt disease?

While contact lenses and corrective lenses cannot treat the underlying retinal disease, they may help optimize remaining vision depending on your specific visual needs. Low vision specialists can also recommend magnification tools and adaptive strategies. Your Boston Vision physician will discuss vision support options as part of your comprehensive care plan.

Schedule Your Consultation for Stargardt Disease Treatment in North Andover, MA

If you or a family member has been diagnosed with Stargardt disease or is experiencing unexplained central vision loss, our team at Boston Vision is here to help. We bring academic-level expertise, advanced diagnostic tools, and a deeply patient-centered approach to every consultation. Patients from North Andover and across the Merrimack Valley trust our physicians to provide honest, knowledgeable guidance on complex retinal diseases and genetic conditions affecting vision. Call us at (617) 566-0062 or contact us online to request an appointment. Individual results may vary, and all treatment decisions are made in partnership with your physician based on your specific diagnosis and health history.

Take Our Vision Correction Self Test
Pay Bill Online